New technologies for neglected diseases: Can tax credits help biotechnology companies advance global health?

ISSN： 1478-565X

Source： Journal of Commercial Biotechnology, Vol.17, Iss.4, 2011-11, pp. : 290-292

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Valuing biotechnology companies: Does classification by technology type help?

By Loh Jacqueline Brooks Robert

Journal of Commercial Biotechnology, Vol. 14, Iss. 2, 2008-04 ,pp. : 118-127

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

How can pharmaceutical and biotechnology companies maintain a high profitability?

By Nickisch Klaus J Greuel Joachim M Bode-Greuel Kerstin M

Journal of Commercial Biotechnology, Vol. 15, Iss. 4, 2009-10 ,pp. : 309-323

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Strategies of biotechnology firms towards new, platform technologies

By Persidis Aris

International Journal of Biotechnology, Vol. 3, Iss. 1-2, 2003-07 ,pp. : 23-32

Inderscience Publishers

Access to resources Recommend Favorite

Biotechnology: The underutilised tool in the fight for global health and security

By Sunderland A

Journal of Commercial Biotechnology, Vol. 9, Iss. 1, 2002-09 ,pp. : 11-13

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Bioethical concerns in Japanese biotechnology companies

By Kato Makina

Journal of Commercial Biotechnology, Vol. 12, Iss. 3, 2006-04 ,pp. : 205-212

Palgrave Macmillan Ltd

Access to resources Recommend Favorite